SERPIN B 13 AS A MARKER FOR SQUAMOUS CELL CARCINOMA OF THE LUNG

摘要

The present invention relates to a method aiding in the assessment of squamous cell carcinoma (= SCC). It discloses the use of the protein serpin B13 as a marker of SCC. Furthermore, it relates to a method for assessing lung cancer in a tissue sample derived from a patient having non-small cell lung carcinoma (= NSCLC) and for differentiating SCC from adenocarcinoma or large cell carcinoma of the lung.